Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	L27 domain binding	LIN7C LIN7A LIN7B	2.50e-06	4	172	3	GO:0097016
GeneOntologyMolecularFunction	[heparan sulfate]-glucosamine N-sulfotransferase activity	NDST1 NDST4 NDST3	2.50e-06	4	172	3	GO:0015016
GeneOntologyMolecularFunction	N-acetylglucosamine deacetylase activity	NDST1 NDST4 NDST3	2.50e-06	4	172	3	GO:0050119
GeneOntologyMolecularFunction	steroid 11-beta-monooxygenase activity	CYP11B1 CYP11B2	7.38e-05	2	172	2	GO:0004507
GeneOntologyMolecularFunction	corticosterone 18-monooxygenase activity	CYP11B1 CYP11B2	7.38e-05	2	172	2	GO:0047783
GeneOntologyMolecularFunction	D-glucose:proton symporter activity	SLC2A4 SLC45A1	2.20e-04	3	172	2	GO:0005356
GeneOntologyMolecularFunction	hexose:proton symporter activity	SLC2A4 SLC45A1	2.20e-04	3	172	2	GO:0009679
GeneOntologyMolecularFunction	heparan sulfate N-deacetylase activity	NDST1 NDST3	2.20e-04	3	172	2	GO:0102140
GeneOntologyMolecularFunction	heparan sulfate sulfotransferase activity	NDST1 NDST4 NDST3	2.65e-04	15	172	3	GO:0034483
GeneOntologyMolecularFunction	PDZ domain binding	LIN7C LIN7A SHISA9 LIN7B KIDINS220 LRP2	6.93e-04	123	172	6	GO:0030165
GeneOntologyMolecularFunction	integrin binding involved in cell-matrix adhesion	EMILIN1 SVEP1	7.25e-04	5	172	2	GO:0098640
GeneOntologyBiologicalProcess	maintenance of epithelial cell apical/basal polarity	LIN7C LIN7A LIN7B CRB2	1.44e-06	11	171	4	GO:0045199
GeneOntologyBiologicalProcess	maintenance of apical/basal cell polarity	LIN7C LIN7A LIN7B CRB2	2.14e-06	12	171	4	GO:0035090
GeneOntologyBiologicalProcess	maintenance of cell polarity	LIN7C LIN7A LIN7B CRB2	1.99e-05	20	171	4	GO:0030011
GeneOntologyBiologicalProcess	protein localization to basolateral plasma membrane	LIN7C LIN7A LIN7B	3.04e-05	8	171	3	GO:1903361
GeneOntologyBiologicalProcess	heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	NDST1 NDST4 NDST3	3.04e-05	8	171	3	GO:0015014
GeneOntologyBiologicalProcess	mitochondrial RNA metabolic process	GRSF1 YARS2 KANSL3 PNPT1 SARS2	8.41e-05	54	171	5	GO:0000959
GeneOntologyBiologicalProcess	heparin biosynthetic process	NDST1 NDST4 NDST3	8.80e-05	11	171	3	GO:0030210
GeneOntologyCellularComponent	MPP7-DLG1-LIN7 complex	LIN7C LIN7A LIN7B	5.50e-06	5	173	3	GO:0097025
GeneOntologyCellularComponent	postsynaptic density membrane	LIN7C LRFN3 LIN7A SHISA9 LIN7B LRFN4 CELSR3 SLITRK5 DAGLA	6.55e-06	157	173	9	GO:0098839
GeneOntologyCellularComponent	postsynaptic specialization membrane	LIN7C LRFN3 LIN7A SHISA9 LIN7B LRFN4 CELSR3 SLITRK5 DAGLA	4.68e-05	201	173	9	GO:0099634
GeneOntologyCellularComponent	postsynaptic membrane	LIN7C SYNE1 LRFN3 SHC4 LIN7A SHISA9 LIN7B SLITRK2 LRFN4 CELSR3 SLITRK5 DAGLA	1.47e-04	405	173	12	GO:0045211
GeneOntologyCellularComponent	basolateral plasma membrane	ABCC3 LIN7C RASGRF1 AQP8 AQP4 SLC2A1 LIN7A LIN7B SLC22A8 PKD1	3.46e-04	320	173	10	GO:0016323
GeneOntologyCellularComponent	equatorial microtubule organizing center	TUBGCP2 TUBGCP6	6.70e-04	5	173	2	GO:0000923
GeneOntologyCellularComponent	basal plasma membrane	ABCC3 LIN7C RASGRF1 AQP8 AQP4 SLC2A1 LIN7A LIN7B SLC22A8 PKD1	7.58e-04	354	173	10	GO:0009925
GeneOntologyCellularComponent	lamellipodium membrane	PIEZO1 APC2 CSPG4	7.64e-04	22	173	3	GO:0031258
GeneOntologyCellularComponent	extracellular matrix	COL4A3 COL6A3 COL6A5 CHADL NYX EMILIN1 SVEP1 TGFBI LRIG1 NCAN CSPG4 ANGPTL4 FIBCD1 ADAMTS15	1.15e-03	656	173	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	COL4A3 COL6A3 COL6A5 CHADL NYX EMILIN1 SVEP1 TGFBI LRIG1 NCAN CSPG4 ANGPTL4 FIBCD1 ADAMTS15	1.19e-03	658	173	14	GO:0030312
GeneOntologyCellularComponent	basal part of cell	ABCC3 LIN7C RASGRF1 AQP8 AQP4 SLC2A1 LIN7A LIN7B SLC22A8 PKD1	1.24e-03	378	173	10	GO:0045178
GeneOntologyCellularComponent	Cdc73/Paf1 complex	RTF1 CTR9	1.39e-03	7	173	2	GO:0016593
MousePheno	abnormal urine corticosterone level	CYP11B1 CYP11B2 CRH	3.66e-06	4	137	3	MP:0011548
MousePheno	increased adrenal gland zona fasciculata size	CYP11B1 CYP11B2 CRH	9.08e-06	5	137	3	MP:0014286
MousePheno	behavioral arrest	SLC2A1 LRFN4 HCRT	1.80e-05	6	137	3	MP:0008035
MousePheno	increased urine hormone level	CYP11B1 CYP11B2 CRH	1.80e-05	6	137	3	MP:0014458
MousePheno	abnormal adrenal gland zona fasciculata morphology	CYP11B1 CYP11B2 CRH NNT	3.05e-05	19	137	4	MP:0008294
MousePheno	abnormal urine hormone level	CYP11B1 CYP11B2 CRH	3.13e-05	7	137	3	MP:0011538
MousePheno	increased circulating angiotensin II level	CYP11B1 CYP11B2 VAV3	4.97e-05	8	137	3	MP:0031232
MousePheno	increased angiotensin II level	CYP11B1 CYP11B2 VAV3	4.97e-05	8	137	3	MP:0031229
MousePheno	abnormal urine progesterone level	CYP11B1 CYP11B2	9.54e-05	2	137	2	MP:0011545
MousePheno	abnormal urine deoxycorticosterone level	CYP11B1 CYP11B2	9.54e-05	2	137	2	MP:0011552
MousePheno	decreased urine corticosterone level	CYP11B1 CYP11B2	9.54e-05	2	137	2	MP:0011550
MousePheno	increased urine deoxycorticosterone level	CYP11B1 CYP11B2	9.54e-05	2	137	2	MP:0011553
MousePheno	increased urine progesterone level	CYP11B1 CYP11B2	9.54e-05	2	137	2	MP:0011546
MousePheno	abnormal adrenocortical cell morphology	CYP11B1 CYP11B2 NNT	1.05e-04	10	137	3	MP:0008291
MousePheno	abnormal adrenal gland zona fasciculata size	CYP11B1 CYP11B2 CRH	1.43e-04	11	137	3	MP:0014284
MousePheno	abnormal cyst	NDST1 LIN7C CYP11B1 CYP11B2 CCDC88B ONECUT1 PKD1 LRP2 PRKDC PCCB HR	1.49e-04	294	137	11	MP:0031310
MousePheno	abnormal circulating angiotensin II level	CYP11B1 CYP11B2 VAV3	1.90e-04	12	137	3	MP:0031230
MousePheno	abnormal angiotensin II level	CYP11B1 CYP11B2 VAV3	1.90e-04	12	137	3	MP:0031227
MousePheno	cleft upper lip	CPLANE2 NDST1 ERMP1 KIF7	1.99e-04	30	137	4	MP:0005170
MousePheno	abnormal lip shape	CPLANE2 NDST1 ERMP1 KIF7	1.99e-04	30	137	4	MP:0003771
MousePheno	abnormal sucrose solution preference	SETD1A SLITRK2	2.84e-04	3	137	2	MP:0020379
MousePheno	abnormal non-rapid eye movement sleep pattern	SIK3 SLC2A1 HCRT	3.10e-04	14	137	3	MP:0012289
MousePheno	increased renin activity	CYP11B1 CYP11B2 VAV3	3.10e-04	14	137	3	MP:0005582
MousePheno	abnormal aorta morphology	NDST1 ERMP1 HM13 EMILIN1 KIF7 ZIC3 PKD1 LRP2 VAV3	3.72e-04	225	137	9	MP:0000272
MousePheno	decreased thymus weight	WHRN CYP11B1 CYP11B2 HR	4.08e-04	36	137	4	MP:0004956
Domain	Cys-rich_flank_reg_C	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	1.24e-07	90	169	9	IPR000483
Domain	LRRCT	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	1.24e-07	90	169	9	SM00082
Domain	LRRNT	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	2.59e-07	98	169	9	IPR000372
Domain	LRRNT	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	2.59e-07	98	169	9	SM00013
Domain	Heparan_SO4_deacetylase	NDST1 NDST4 NDST3	2.89e-06	4	169	3	IPR021930
Domain	HSNSD	NDST1 NDST4 NDST3	2.89e-06	4	169	3	PF12062
Domain	Leu-rich_rpt	LRFN3 CHADL NYX STK11IP SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 PPP1R37 FBXL20 GP5	6.89e-06	271	169	12	IPR001611
Domain	LRR_8	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	2.61e-05	171	169	9	PF13855
Domain	LRR_TYP	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	3.43e-05	177	169	9	SM00369
Domain	Leu-rich_rpt_typical-subtyp	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 GP5	3.43e-05	177	169	9	IPR003591
Domain	-	LRFN3 CHADL NYX STK11IP SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 PPP1R37 FBXL20 GP5	3.70e-05	321	169	12	3.80.10.10
Domain	L_dom-like	LRFN3 CHADL NYX STK11IP SLITRK2 LRFN4 LRIG1 PKD1 SLITRK5 PPP1R37 FBXL20 GP5	4.56e-05	328	169	12	IPR032675
Domain	Cyt_P450_mitochondrial	CYP11B1 CYP11B2	8.14e-05	2	169	2	IPR002399
Domain	L27_C	LIN7C LIN7A LIN7B	8.34e-05	10	169	3	IPR014775
Domain	L27	LIN7C LIN7A LIN7B	8.34e-05	10	169	3	PF02828
Domain	LRRNT	NYX SLITRK2 LRIG1 PKD1 SLITRK5	1.15e-04	53	169	5	PF01462
Domain	LRR_1	LRFN3 CHADL NYX SLITRK2 LRFN4 LRIG1 SLITRK5 FBXL20 GP5	1.76e-04	219	169	9	PF00560
Domain	L27	LIN7C LIN7A LIN7B	1.95e-04	13	169	3	SM00569
Domain	L27	LIN7C LIN7A LIN7B	1.95e-04	13	169	3	PS51022
Domain	L27_dom	LIN7C LIN7A LIN7B	1.95e-04	13	169	3	IPR004172
Domain	EGF_3	ADAM18 VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	2.96e-04	235	169	9	PS50026
Domain	MFS_sugar_transport-like	SLC2A1 SLC2A4 SLC22A8 SLC22A31	3.04e-04	36	169	4	IPR005828
Domain	Sugar_tr	SLC2A1 SLC2A4 SLC22A8 SLC22A31	3.04e-04	36	169	4	PF00083
Domain	EGF-like_dom	ADAM18 VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	4.52e-04	249	169	9	IPR000742
Domain	LRR	CHADL STK11IP SLITRK2 LRIG1 PKD1 SLITRK5 PPP1R37 GP5	4.98e-04	201	169	8	PS51450
Domain	EGF_1	ADAM18 VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	5.37e-04	255	169	9	PS00022
Domain	EGF-like_CS	ADAM18 VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	6.34e-04	261	169	9	IPR013032
Domain	EGF_2	ADAM18 VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	7.07e-04	265	169	9	PS01186
Domain	Spc97_Spc98	TUBGCP2 TUBGCP6	8.00e-04	5	169	2	PF04130
Domain	GCP	TUBGCP2 TUBGCP6	8.00e-04	5	169	2	IPR007259
Domain	DUF4704	NBEAL1 NBEAL2	8.00e-04	5	169	2	IPR031570
Domain	DUF4704	NBEAL1 NBEAL2	8.00e-04	5	169	2	PF15787
Domain	Collagen	COL4A3 COL6A3 COL6A5 EMILIN1 SCARA5	1.05e-03	85	169	5	IPR008160
Domain	Collagen	COL4A3 COL6A3 COL6A5 EMILIN1 SCARA5	1.05e-03	85	169	5	PF01391
Domain	PH_BEACH	NBEAL1 NBEAL2	1.19e-03	6	169	2	PF14844
Domain	EGF	VWDE SVEP1 HHIP CELSR3 NCAN LRP2 ASTN1 CRB2	1.37e-03	235	169	8	SM00181
Domain	VWA	COL6A3 VWA8 COL6A5 SVEP1	1.65e-03	56	169	4	PF00092
Domain	-	NBEAL1 SVEP1 CELSR3 CSPG4 CRB2	1.72e-03	95	169	5	2.60.120.200
Pathway	REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES	LIN7C LRFN3 LIN7A LIN7B SLITRK2 LRFN4 SLITRK5	1.12e-05	87	124	7	M27617
Pathway	REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH	COL4A3 COL6A3 SPTBN2 COL6A5 NCAN PSPN	1.85e-05	63	124	6	M11187
Pathway	REACTOME_NCAM1_INTERACTIONS	COL4A3 COL6A3 COL6A5 NCAN PSPN	3.18e-05	42	124	5	M7169
Pathway	KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS	NDST1 NDST4 NDST3	1.04e-04	11	124	3	M47921
Pathway	REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM	NDST1 NDST4 NDST3 NCAN CSPG4	1.41e-04	57	124	5	M692
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ABCC3 DPH2 SETD1A NDST1 MAN2A2 VWA8 MTG2 PIEZO1 KHNYN STK11IP SLC2A1 ITPR3 KANSL3 SARS2 CELSR3 IL17RE NBEAL2 MCM3AP CSPG4 PKD1 PRKDC SLC45A1 SDHA HR	1.91e-09	1105	175	24	35748872
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	DPH2 CCPG1 VWA8 SYNE1 PIEZO1 SPTBN2 COX15 RICTOR SIK3 HM13 GRSF1 SLC2A1 GTF3C3 KIF7 ITPR3 TUBGCP6 PNPT1 NOP58 SARS2 KIDINS220 CTR9 DDX18 EIF2A CARS2 SDHA	1.30e-07	1487	175	25	33957083
Pubmed	Lowered expression of heparan sulfate/heparin biosynthesis enzyme N-deacetylase/n-sulfotransferase 1 results in increased sulfation of mast cell heparin.	NDST1 NDST4 NDST3	4.99e-07	4	175	3	22049073
Pubmed	Renal defects associated with improper polarization of the CRB and DLG polarity complexes in MALS-3 knockout mice.	LIN7C LIN7A LIN7B	4.99e-07	4	175	3	17923534
Pubmed	Association study of brain-derived neurotrophic factor (BDNF) and LIN-7 homolog (LIN-7) genes with adult attention-deficit/hyperactivity disorder.	LIN7C LIN7A LIN7B	4.99e-07	4	175	3	18286632
Pubmed	Regulated translation of heparan sulfate N-acetylglucosamine N-deacetylase/n-sulfotransferase isozymes by structured 5'-untranslated regions and internal ribosome entry sites.	NDST1 NDST4 NDST3	4.99e-07	4	175	3	12070138
Pubmed	MALS is a binding partner of IRSp53 at cell-cell contacts.	LIN7C LIN7A LIN7B	4.99e-07	4	175	3	14596909
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SETD1A VWA8 PIEZO1 SRCIN1 ERMP1 SIK3 NUP205 KANSL3 TUBGCP6 CELSR3 INTS2 NBEAL2 MAML2 DAGLA	5.44e-07	529	175	14	14621295
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ABCC3 DPH2 ARHGEF28 NDUFAF5 COX15 RICTOR PAPSS2 PREX2 YARS2 NUP205 RTF1 NOP58 UBE2J2 PELP1 INTS2 UBE3D CTR9 MCM3AP CCDC120 MAML2 NKAP ALOX12	9.98e-07	1327	175	22	32694731
Pubmed	Characterization of MALS/Velis-1, -2, and -3: a family of mammalian LIN-7 homologs enriched at brain synapses in association with the postsynaptic density-95/NMDA receptor postsynaptic complex.	LIN7C LIN7A LIN7B	1.24e-06	5	175	3	10341223
Pubmed	The stardust family protein MPP7 forms a tripartite complex with LIN7 and DLG1 that regulates the stability and localization of DLG1 to cell junctions.	LIN7C LIN7A LIN7B	1.24e-06	5	175	3	17237226
Pubmed	Contrasting localizations of MALS/LIN-7 PDZ proteins in brain and molecular compensation in knockout mice.	LIN7C LIN7A LIN7B	1.24e-06	5	175	3	11104771
Pubmed	Multiple isozymes of heparan sulfate/heparin GlcNAc N-deacetylase/GlcN N-sulfotransferase. Structure and activity of the fourth member, NDST4.	NDST1 NDST4 NDST3	1.24e-06	5	175	3	11087757
Pubmed	MALS-3 regulates polarity and early neurogenesis in the developing cerebral cortex.	LIN7C LIN7A LIN7B CRB2	1.40e-06	17	175	4	18403412
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	NDST1 SYNE1 TAF1C SPTBN2 APC2 WHAMM GAS7 ZIC3 SARS2 CELSR3 CTR9 DDX18 ASB3 USP32 PKD1 LRP2 ASTN1 PRKDC CARS2 PCCB SDHA	2.25e-06	1285	175	21	35914814
Pubmed	Circadian rise in maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal insufficiency.	CYP11B1 CYP11B2 CRH	2.48e-06	6	175	3	10861000
Pubmed	A unified assembly mode revealed by the structures of tetrameric L27 domain complexes formed by mLin-2/mLin-7 and Patj/Pals1 scaffold proteins.	LIN7C LIN7A LIN7B	2.48e-06	6	175	3	15863617
Pubmed	Hyperoxia prevents the dynamic neonatal increases in lung mesenchymal cell diversity.	CRH TGFBI HHIP	2.48e-06	6	175	3	38263350
Pubmed	CLEC16A interacts with retromer and TRIM27, and its loss impairs endosomal trafficking and neurodevelopment.	VWA8 MTG2 COX15 RICTOR TUBGCP2 HM13 STK11IP SLC2A1 KIF7 TUBGCP6 SARS2 KIDINS220 SLC25A12 PCCB	2.67e-06	606	175	14	36538041
Pubmed	A tripartite protein complex with the potential to couple synaptic vesicle exocytosis to cell adhesion in brain.	LIN7C LIN7A LIN7B	4.32e-06	7	175	3	9753324
Pubmed	Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression.	SLC25A21 CYP11B1 CYP11B2 MTG2 CYP27B1 COX15 HDDC2 GRSF1 YARS2 PNPT1 SARS2 SLC25A12 CARS2 PCCB NNT SLC25A23 SDHA	4.92e-06	926	175	17	20877624
Pubmed	Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.	SLC25A21 NDUFAF5 VWA8 CYP11B1 PRXL2B CYP11B2 MTG2 CYP27B1 COX15 GRSF1 YARS2 PNPT1 SARS2 SLC25A12 CARS2 PCCB NNT SLC25A23 SDHA	5.08e-06	1136	175	19	34800366
Pubmed	FGF signaling sustains the odontogenic fate of dental mesenchyme by suppressing β-catenin signaling.	NDST1 NDST4 NDST3	6.88e-06	8	175	3	24067353
Pubmed	The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.	CPXM2 ADAM18 LRFN3 SH2D3A SHC4 LCN6 KIF7 LIN7B NDST3 HHIP SLITRK2 ST3GAL5 IL17RE SCARA5 NBEAL2 ANGPTL4 FIBCD1	1.10e-05	985	175	17	12975309
Pubmed	Global genetic analysis in mice unveils central role for cilia in congenital heart disease.	CPLANE2 NDST1 ERMP1 KIF7 PKD1 LRP2	1.20e-05	100	175	6	25807483
Pubmed	A multiprotein trafficking complex composed of SAP97, CASK, Veli, and Mint1 is associated with inward rectifier Kir2 potassium channels.	LIN7C LIN7A LIN7B	1.46e-05	10	175	3	14960569
Pubmed	Variability in Streptavidin-Sepharose Matrix Quality Can Significantly Affect Proximity-Dependent Biotinylation (BioID) Data.	NDUFAF5 VWA8 GRSF1 SLC2A1 YARS2 PNPT1 SARS2 SLC25A12 CARS2 NNT SDHA	1.51e-05	438	175	11	32628020
Pubmed	Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones.	CYP11B1 CYP11B2 CYP27B1 LRP2	1.75e-05	31	175	4	15583024
Pubmed	Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain.	NDST1 NDST4 NDST3	2.01e-05	11	175	3	15944372
Pubmed	A mitochondrial protein compendium elucidates complex I disease biology.	SLC25A21 NDUFAF5 CYP11B1 CYP11B2 MTG2 CYP27B1 COX15 HDDC2 GRSF1 YARS2 PNPT1 SARS2 SLC25A12 PCCB NNT SLC25A23 SDHA	2.39e-05	1047	175	17	18614015
Pubmed	Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension.	CYP11B1 CYP11B2	2.52e-05	2	175	2	23150505
Pubmed	GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	35012455
Pubmed	Role of genetic variation in regulation of aldosterone biosynthesis.	CYP11B1 CYP11B2	2.52e-05	2	175	2	21164264
Pubmed	Neuron/Glial Antigen 2-Type VI Collagen Interactions During Murine Temporomandibular Joint Osteoarthritis.	COL6A3 CSPG4	2.52e-05	2	175	2	30635602
Pubmed	The hamster adrenal cytochrome P450C11 has equipotent 11beta-hydroxylase and 19-hydroxylase activities, but no aldosterone synthase activity.	CYP11B1 CYP11B2	2.52e-05	2	175	2	8645611
Pubmed	Regulation of GLUT transporters by flavonoids in androgen-sensitive and -insensitive prostate cancer cells.	SLC2A1 SLC2A4	2.52e-05	2	175	2	24932809
Pubmed	Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice.	PRKDC HR	2.52e-05	2	175	2	21525235
Pubmed	Expression and localization of cytochrome P450(11beta,aldo) mRNA in the frog brain.	CYP11B1 CYP11B2	2.52e-05	2	175	2	12231255
Pubmed	A de novo unequal cross-over mutation between CYP11B1 and CYP11B2 genes causes familial hyperaldosteronism type I.	CYP11B1 CYP11B2	2.52e-05	2	175	2	20634641
Pubmed	Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.	CYP11B1 CYP11B2	2.52e-05	2	175	2	1303253
Pubmed	Indinavir uncovers different contributions of GLUT4 and GLUT1 towards glucose uptake in muscle and fat cells and tissues.	SLC2A1 SLC2A4	2.52e-05	2	175	2	12712244
Pubmed	Diabetes and obesity during pregnancy alter insulin signalling and glucose transporter expression in maternal skeletal muscle and subcutaneous adipose tissue.	SLC2A1 SLC2A4	2.52e-05	2	175	2	19955252
Pubmed	Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans.	CYP11B1 CYP11B2	2.52e-05	2	175	2	1741400
Pubmed	Effects of intron conversion in the human CYP11B2 gene on its transcription and blood pressure regulation in transgenic mice.	CYP11B1 CYP11B2	2.52e-05	2	175	2	32540969
Pubmed	Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.	CYP11B1 CYP11B2	2.52e-05	2	175	2	26047574
Pubmed	Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.	NCAN CSPG4	2.52e-05	2	175	2	22628090
Pubmed	Aldosterone synthase knockout mouse as a model for sodium-induced endothelial sodium channel up-regulation in vascular endothelium.	CYP11B1 CYP11B2	2.52e-05	2	175	2	26324851
Pubmed	Microsatellite polymorphism analysis allows the individual assignment of the rat 11 beta-hydroxylase gene (Cyp11b1) and the rat aldosterone synthase gene (Cyp11b2) to chromosome 7 using rat x mouse somatic cell hybrids and identifies differences between and within various rat strains.	CYP11B1 CYP11B2	2.52e-05	2	175	2	7669222
Pubmed	Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron.	CYP11B1 CYP11B2	2.52e-05	2	175	2	22933298
Pubmed	Differential effects of GLUT1 or GLUT4 overexpression on hexosamine biosynthesis by muscles of transgenic mice.	SLC2A1 SLC2A4	2.52e-05	2	175	2	8798515
Pubmed	Structural and functional analysis of the promoter region of the gene encoding mouse steroid 11 beta-hydroxylase.	CYP11B1 CYP11B2	2.52e-05	2	175	2	2783417
Pubmed	Cloning and expression of a cDNA for human cytochrome P-450aldo as related to primary aldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	2256920
Pubmed	Association of DNA polymorphisms within the CYP11B2/CYP11B1 locus and postoperative hypertension risk in the patients with aldosterone-producing adenomas.	CYP11B1 CYP11B2	2.52e-05	2	175	2	20708777
Pubmed	Molecular genetic studies on the biosynthesis of aldosterone in humans.	CYP11B1 CYP11B2	2.52e-05	2	175	2	22217843
Pubmed	Mechanistic study of polychlorinated biphenyl 126-induced CYP11B1 and CYP11B2 up-regulation.	CYP11B1 CYP11B2	2.52e-05	2	175	2	16396990
Pubmed	[123 I]Iodometomidate for molecular imaging of adrenocortical cytochrome P450 family 11B enzymes.	CYP11B1 CYP11B2	2.52e-05	2	175	2	18397978
Pubmed	Somatic cell-like features of cloned mouse embryos prepared with cultured myoblast nuclei.	SLC2A1 SLC2A4	2.52e-05	2	175	2	12606377
Pubmed	Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.	CYP11B1 CYP11B2	2.52e-05	2	175	2	1518866
Pubmed	Procollagen I-expressing renin cell precursors.	CYP11B1 CYP11B2	2.52e-05	2	175	2	23761669
Pubmed	A potential role for glucose transporters in the evolution of human brain size.	SLC2A1 SLC2A4	2.52e-05	2	175	2	21986508
Pubmed	Extracellular ATP and glutamate drive pyruvate production and energy demand to regulate mitochondrial respiration in astrocytes.	SLC25A12 SLC25A23	2.52e-05	2	175	2	30623988
Pubmed	Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).	CYP11B1 CYP11B2	2.52e-05	2	175	2	2592361
Pubmed	Differential effects of GLUT-1 or GLUT-4 overexpression on insulin responsiveness in transgenic mice.	SLC2A1 SLC2A4	2.52e-05	2	175	2	7977725
Pubmed	Aldosterone deficiency prevents high-fat-feeding-induced hyperglycaemia and adipocyte dysfunction in mice.	CYP11B1 CYP11B2	2.52e-05	2	175	2	23314847
Pubmed	Effect of variation in CYP11B1 and CYP11B2 on corticosteroid phenotype and hypothalamic-pituitary-adrenal axis activity in hypertensive and normotensive subjects.	CYP11B1 CYP11B2	2.52e-05	2	175	2	17980006
Pubmed	Association between aldosterone production and variation in the 11beta-hydroxylase (CYP11B1) gene.	CYP11B1 CYP11B2	2.52e-05	2	175	2	16984984
Pubmed	Evidence for local aldosterone synthesis in the large intestine of the mouse.	CYP11B1 CYP11B2	2.52e-05	2	175	2	35288482
Pubmed	Homeostatic responses in the adrenal cortex to the absence of aldosterone in mice.	CYP11B1 CYP11B2	2.52e-05	2	175	2	15731365
Pubmed	Interleukin-17 Receptor E and C-C Motif Chemokine Receptor 10 Identify Heterogeneous T Helper 17 Subsets in a Mouse Dry Eye Disease Model.	CCR10 IL17RE	2.52e-05	2	175	2	35144761
Pubmed	Sequence, tissue distribution, and differential expression of mRNA for a putative insulin-responsive glucose transporter in mouse 3T3-L1 adipocytes.	SLC2A1 SLC2A4	2.52e-05	2	175	2	2654938
Pubmed	Kidins220/ARMS interacts with Pdzrn3, a protein containing multiple binding domains.	KIDINS220 PDZRN3	2.52e-05	2	175	2	22609016
Pubmed	Phenotypic consequences of variation across the aldosterone synthase and 11-beta hydroxylase locus in a hypertensive cohort: data from the MRC BRIGHT Study.	CYP11B1 CYP11B2	2.52e-05	2	175	2	17651452
Pubmed	Expression of CYP11B1 and CYP11B2 in adrenal adenoma correlates with clinical characteristics of primary aldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	34743356
Pubmed	Polymorphisms in CYP11B2 and CYP11B1 genes associated with primary hyperaldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	20339375
Pubmed	Insulin-sensitive regulation of glucose transport and GLUT4 translocation in skeletal muscle of GLUT1 transgenic mice.	SLC2A1 SLC2A4	2.52e-05	2	175	2	9854024
Pubmed	Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	20808686
Pubmed	Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.	CYP11B1 CYP11B2	2.52e-05	2	175	2	21519965
Pubmed	Diagnosis of glucocorticoid-remediable aldosteronism in hypertensive children.	CYP11B1 CYP11B2	2.52e-05	2	175	2	21625068
Pubmed	Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.	CYP11B1 CYP11B2	2.52e-05	2	175	2	16110193
Pubmed	Chimeric CYP11B2/CYP11B1 causing 11β-hydroxylase deficiency in Chinese patients with congenital adrenal hyperplasia.	CYP11B1 CYP11B2	2.52e-05	2	175	2	26066897
Pubmed	Targeting glucose consumption and autophagy in myeloma with the novel nucleoside analogue 8-aminoadenosine.	SLC2A1 SLC2A4	2.52e-05	2	175	2	19648108
Pubmed	The Glut1 and Glut4 glucose transporters are differentially expressed during perinatal and postnatal erythropoiesis.	SLC2A1 SLC2A4	2.52e-05	2	175	2	18796630
Pubmed	Cytotoxicity and decreased corticosterone production in adrenocortical Y-1 cells by 3-methylsulfonyl-DDE and structurally related molecules.	CYP11B1 CYP11B2	2.52e-05	2	175	2	18651133
Pubmed	[Expression and significance of GLUT-1 and DNA-PKcs in serous ovarian tumors].	SLC2A1 PRKDC	2.52e-05	2	175	2	17991316
Pubmed	A new presentation of the chimeric CYP11B1/CYP11B2 gene with low prevalence of primary aldosteronism and atypical gene segregation pattern.	CYP11B1 CYP11B2	2.52e-05	2	175	2	22083159
Pubmed	Editorial: polymorphisms in CYP11B genes and 11-hydroxylase activity.	CYP11B1 CYP11B2	2.52e-05	2	175	2	15699546
Pubmed	Cyp11b1 is induced in the murine gonad by luteinizing hormone/human chorionic gonadotropin and involved in the production of 11-ketotestosterone, a major fish androgen: conservation and evolution of the androgen metabolic pathway.	CYP11B1 CYP11B2	2.52e-05	2	175	2	18162527
Pubmed	Chronic activation of adrenal Gq signaling induces Cyp11b2 expression in the zona fasciculata and hyperaldosteronism.	CYP11B1 CYP11B2	2.52e-05	2	175	2	38341019
Pubmed	Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease.	SVEP1 ANGPTL4	2.52e-05	2	175	2	26934567
Pubmed	3T3-L1 adipocyte glucose transporter (HepG2 class): sequence and regulation of protein and mRNA expression by insulin, differentiation, and glucose starvation.	SLC2A1 SLC2A4	2.52e-05	2	175	2	2190533
Pubmed	Adrenal CYP11B1/2 expression in primary aldosteronism: immunohistochemical analysis using novel monoclonal antibodies.	CYP11B1 CYP11B2	2.52e-05	2	175	2	24837548
Pubmed	Aldosterone deficiency in mice burdens respiration and accentuates diet-induced hyperinsulinemia and obesity.	CYP11B1 CYP11B2	2.52e-05	2	175	2	30046010
Pubmed	Familial and phenotypic associations of the aldosterone Renin ratio.	CYP11B1 CYP11B2	2.52e-05	2	175	2	19820005
Pubmed	Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake.	SLC2A1 SLC2A4	2.52e-05	2	175	2	28589878
Pubmed	Metabolic and endocrine differences between the mutation whirler and normal female mice.	WHRN HM13	2.52e-05	2	175	2	6034501
Pubmed	Aldosterone deficiency and mineralocorticoid receptor antagonism prevent angiotensin II-induced cardiac, renal, and vascular injury.	CYP11B1 CYP11B2	2.52e-05	2	175	2	22622494
Pubmed	Expression of a RhoA-Specific Guanine Nucleotide Exchange Factor, p190RhoGEF, in Mouse Macrophages Negatively Affects M1 Polarization and Inflammatory Responses.	ARHGEF28 RASGRF1	2.52e-05	2	175	2	35422804
Pubmed	Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.	CYP11B1 CYP11B2	2.52e-05	2	175	2	15062555
Pubmed	Disturbed homeostasis in sodium-restricted mice heterozygous and homozygous for aldosterone synthase gene disruption.	CYP11B1 CYP11B2	2.52e-05	2	175	2	17075030
Pubmed	Polymorphic variation in the 11beta-hydroxylase gene associates with reduced 11-hydroxylase efficiency.	CYP11B1 CYP11B2	2.52e-05	2	175	2	17075029
GeneFamily	PDZ domain containing\|Crumbs complex	LIN7C LIN7A LIN7B CRB2	2.27e-07	9	120	4	1223
GeneFamily	Cytochrome P450 family 11	CYP11B1 CYP11B2	1.30e-04	3	120	2	1007
GeneFamily	PDZ domain containing	WHRN LIN7C PREX2 LIN7A LIN7B PDZRN3	5.32e-04	152	120	6	1220
GeneFamily	Tetratricopeptide repeat domain containing\|Paf1/RNA polymerase II complex	RTF1 CTR9	6.44e-04	6	120	2	1029
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 NBEAL2	1.53e-03	9	120	2	1230
GeneFamily	Sulfotransferases, membrane bound	NDST1 NDST4 NDST3	1.88e-03	37	120	3	763
GeneFamily	Collagens	COL4A3 COL6A3 COL6A5	3.52e-03	46	120	3	490
GeneFamily	Aquaporins	AQP8 AQP4	3.77e-03	14	120	2	305
Coexpression	NABA_CORE_MATRISOME	COL4A3 COL6A3 COL6A5 CHADL NYX EMILIN1 VWDE SVEP1 TGFBI NCAN	1.26e-05	270	172	10	MM17057
Coexpression	NABA_CORE_MATRISOME	COL4A3 COL6A3 COL6A5 CHADL NYX EMILIN1 VWDE SVEP1 TGFBI NCAN	1.48e-05	275	172	10	M5884
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	COL4A3 ABCC3 SH2D3A MAGEE2 AQP4 ITPR3 IL17RE NBEAL2 GALNT5 SLC22A31	6.56e-09	199	174	10	f8846446ebbc4948cdc69640782db1358bbdc486
ToppCell	Parenchyma_COVID-19-Epithelial-TX-AT1\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	COL4A3 ABCC3 SH2D3A MAGEE2 AQP4 ITPR3 IL17RE NBEAL2 GALNT5 SLC22A31	6.56e-09	199	174	10	fe9f5bc317be0c35bd96311bf0b3c7b91d98acc5
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-AT1\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	COL4A3 ABCC3 SH2D3A MAGEE2 AQP4 ITPR3 IL17RE NBEAL2 GALNT5 SLC22A31	6.56e-09	199	174	10	3e35ee426ef06f9af568c37349b62dd1ee9b97ea
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 PAPSS2 EMILIN1 PREX2 SVEP1 SLITRK5 ADAMTS15 PDZRN3	6.88e-09	200	174	10	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 ADAM18 SVEP1 HHIP SLITRK2 CLEC11A SCARA5 GALNT5	6.33e-08	190	174	9	f61e21d53f2f7804ac6e40ab6c7f69838aa94d6a
ToppCell	droplet-Kidney-nan-3m-Mesenchymal\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 ADAM18 SVEP1 HHIP SLITRK2 CLEC11A SCARA5 GALNT5	6.33e-08	190	174	9	2abeb013bb83c578e67dcb985ba44ca63134950b
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A3 NBEAL1 SH2D3A PAPSS2 AQP4 CRH IL17RE NBEAL2 GALNT5	9.41e-08	199	174	9	d43c605a4ff221cf78d91678c15d2ad20f831c7f
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 PAPSS2 PREX2 SVEP1 SLITRK5 ADAMTS15 PDZRN3	9.41e-08	199	174	9	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 SYNE1 EMILIN1 SLC2A4 LIN7A HHIP SAMD11 PDZRN3	6.95e-07	185	174	8	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 RASGRF1 AQP4 EMILIN1 SVEP1 GSTA4 HHIP SLC22A31	8.84e-07	191	174	8	f00d6824bd138b192a996e9f7de57b235bb24c18
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 GAS7 EMILIN1 SVEP1 CLEC11A SCARA5 ANGPTL4 ADAMTS15	8.84e-07	191	174	8	997abf0cc5873bed0372c4a333ed307fa72774d2
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-Stroma____fibroblast\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 ADAM18 SVEP1 HHIP SLITRK2 SCARA5 GALNT5	8.84e-07	191	174	8	d1205aab0937f2becfcd239610e9b78fb8a0c886
ToppCell	facs-Lung-nan-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 SVEP1 HHIP CLEC11A SCARA5 ANGPTL4 ADAMTS15 PDZRN3	9.56e-07	193	174	8	d9c20a092b507c43fcf7ccb04073fecd27d1749c
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 GAS7 SVEP1 SCARA5 ANGPTL4 ADAMTS15 PDZRN3 HR	1.03e-06	195	174	8	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 AQP4 GSTA4 ITPR3 HHIP ST3GAL5 LRP2 SLC22A31	1.03e-06	195	174	8	6617abca0009ad3d8731f515f91ab275f9ea4c40
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 COL6A5 EMILIN1 SVEP1 SAMD11 CLEC11A SCARA5 PDZRN3	1.07e-06	196	174	8	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL6A5 EMILIN1 SVEP1 CLEC11A SCARA5 MAML2 PDZRN3	1.07e-06	196	174	8	2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 SYNE1 EMILIN1 PREX2 SVEP1 SAMD11 CLEC11A PDZRN3	1.12e-06	197	174	8	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL6A3 COL6A5 EMILIN1 TGFBI HHIP SAMD11 CLEC11A SCARA5	1.16e-06	198	174	8	09be07ebfc3e49c3858e9b74605b69cf4fc28b56
ToppCell	Control_saline-Epithelial_alveolar-AT_1-Differentiating_AT1\|Control_saline / Treatment groups by lineage, cell group, cell type	COL4A3 NBEAL1 SH2D3A PAPSS2 AQP4 IL17RE NBEAL2 GALNT5	1.16e-06	198	174	8	85f424cd9bb3117c9e322031024aabb87696ce47
ToppCell	tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs\|tumor_Lung / Location, Cell class and cell subclass	COL6A3 CPXM2 EMILIN1 SVEP1 SAMD11 CLEC11A SCARA5 PDZRN3	1.16e-06	198	174	8	74f2c7ef702b25a5b99e56121229e678ed992524
ToppCell	Control_saline-Mesenchymal_fibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 SVEP1 CLEC11A SLITRK5 ADAMTS15 PDZRN3	1.25e-06	200	174	8	64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_adventitial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 CPXM2 GAS7 EMILIN1 SVEP1 SAMD11 CLEC11A SCARA5	1.25e-06	200	174	8	fc3c4778841c4b8bac0afb458352614b2c460617
ToppCell	LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL4A3 NBEAL1 SH2D3A AQP4 IL17RE NBEAL2 GALNT5 SLC22A31	1.25e-06	200	174	8	ddfb1f006365bf16203ee49f20200f68220cc288
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A3 SH2D3A PAPSS2 AQP4 CRH IL17RE GALNT5 SLC22A31	1.25e-06	200	174	8	8683445ad5b70748c4a1f12eb77d47623085147e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 PAPSS2 PREX2 SVEP1 ADAMTS15 PDZRN3	1.25e-06	200	174	8	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Tracheal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 SYNE1 GAS7 PAPSS2 PREX2 SVEP1 SCARA5 PDZRN3	1.25e-06	200	174	8	c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts\|Control_saline / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 SVEP1 CLEC11A SLITRK5 ADAMTS15 PDZRN3	1.25e-06	200	174	8	a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	COL6A3 SYNE1 COL6A5 PAPSS2 PREX2 SVEP1 ADAMTS15 PDZRN3	1.25e-06	200	174	8	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 SYNE1 NDST4 GAS7 COL6A5 PREX2 SVEP1 PDZRN3	1.25e-06	200	174	8	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	Adult-Mesenchymal-chondrocyte\|Adult / Lineage, Cell type, age group and donor	COL6A3 EMILIN1 SVEP1 SLITRK2 ANGPTL4 FIBCD1 PDZRN3	3.12e-06	159	174	7	3f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte-Chondrocyte_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPXM2 CHADL PAPSS2 CLEC11A CSPG4 PDZRN3	4.15e-06	166	174	7	37794a84601a2a949d579663d4a4bb8bc8fb5923
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Chondrocyte\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	COL6A3 CPXM2 CHADL PAPSS2 CLEC11A CSPG4 PDZRN3	4.15e-06	166	174	7	81c546c6d847e49e662b81e71992ca0f7a99e890
ToppCell	-Donor_05\|World / lung cells shred on cell class, cell subclass, sample id	COL6A3 COL6A5 EMILIN1 SVEP1 SLITRK2 FIBCD1 PDZRN3	4.67e-06	169	174	7	8ebe9a88111c53a09c25a7b6a164a0a17880458d
ToppCell	droplet-Lung-LUNG-1m-Myeloid-Myeloid_Dendritic_Type_2\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WHRN PPM1M AQP4 ENO4 ST3GAL5 NBEAL2 RNF180	4.67e-06	169	174	7	46f0f0de9a0894c454f93032e7a7a800f47c8276
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAPSS2 CRH SLC2A4 KIF7 TGFBI HHIP SCARA5	5.65e-06	174	174	7	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A3 VWA8 SHC4 GPR108 UBE3D CLEC11A HR	5.87e-06	175	174	7	b4f01e7782cdd107d0817ef601891fd3a382bc35
ToppCell	droplet-Fat-Bat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A3 VWA8 SHC4 GPR108 UBE3D CLEC11A HR	5.87e-06	175	174	7	ef6f811d8e1839f405c3b41090ddf79be57a099f
ToppCell	droplet-Fat-Bat-18m-Mesenchymal\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL4A3 VWA8 SHC4 GPR108 UBE3D CLEC11A HR	5.87e-06	175	174	7	7f7598d46d10bff1cbea42f950bdde1aaa16e9a4
ToppCell	wk_20-22-Epithelial-PNS-Late_Schwann\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	APC2 SHC4 GAS7 SHISA9 SLITRK2 KLHDC8A HR	6.09e-06	176	174	7	81924471d8a8c5bd8eedf294c007e25b6cd3e417
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 COL6A3 NDST4 COL6A5 EMILIN1 TGFBI GALNT5	6.09e-06	176	174	7	852d3da0907fe87c0ef23d75a63ce07619cf0c54
ToppCell	390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ABCC3 COL6A3 NDST4 COL6A5 EMILIN1 TGFBI GALNT5	6.09e-06	176	174	7	d2df1e435996c51213e88270af9f928e9e09a6f5
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 GAS7 ATP10A HHIP CLEC11A GALNT5 HR	6.56e-06	178	174	7	27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee
ToppCell	facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 GAS7 ATP10A HHIP CLEC11A GALNT5 HR	6.56e-06	178	174	7	d348a9550db940d204706529759dc51e30506b5f
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)\|390C / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	6.80e-06	179	174	7	466da2bc3bfc534ffe111c8c28ece7a3cfa08051
ToppCell	390C-Epithelial_cells-Epithelial-B_(AT2)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	6.80e-06	179	174	7	f4bdebb77d39e63160fbf3a85a340ce4d52b7cfd
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	COL4A3 AQP4 ATP10A IL17RE NBEAL2 GALNT5 SLC22A31	7.86e-06	183	174	7	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	RASGRF1 SYNE1 AQP4 ITPR3 HHIP ANGPTL4 SLC22A31	8.44e-06	185	174	7	3b3268e3f99121124e33086cac88479808d31630
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL4A3 COL6A3 GAS7 SVEP1 ST3GAL5 SCARA5 MAML2	9.05e-06	187	174	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	LPS-antiTNF-Epithelial_alveolar\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 ARHGEF28 AQP4 HHIP ST3GAL5 GALNT5 SLC22A31	9.05e-06	187	174	7	201ff693e4756ee3e44762885b3a303a77eb535b
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 KLK7 MFSD6 ATP10A SAMD11 SLC45A1 CRB2	9.05e-06	187	174	7	24c2a3962da364e46e98abeab5f8234376fa26bb
ToppCell	Control-Epithelial-ATI\|Epithelial / Disease state, Lineage and Cell class	COL4A3 NDST1 PAPSS2 AQP4 LIN7A IL17RE NBEAL2	9.05e-06	187	174	7	3a032432f780525f4f4c2a358897d9989b1ecae7
ToppCell	LPS-IL1RA-Epithelial_alveolar\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL4A3 ARHGEF28 AQP4 HHIP ST3GAL5 GALNT5 SLC22A31	9.37e-06	188	174	7	6164d467b612767ceba15de34176bcc8e8c36ab8
ToppCell	Control-Fibroblasts-Adventitial_FB\|Control / group, cell type (main and fine annotations)	COL6A3 CPXM2 GAS7 SVEP1 SCARA5 ADAMTS15 PDZRN3	9.37e-06	188	174	7	706a26c372add839d947749f0521a0e1f5c9b0ec
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 SLITRK2 NCAN CSPG4 SLITRK5 RNF180 HCRT	9.37e-06	188	174	7	006db2c2c44971ca9241c582bc89f258c785f5ed
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHC4 SLITRK2 NCAN CSPG4 SLITRK5 RNF180 HCRT	9.37e-06	188	174	7	d0e6fb4a3b3d79d3512b5500062ea285495ae526
ToppCell	AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	RASGRF1 AQP4 ITPR3 HHIP LRP2 GALNT5 SLC22A31	9.70e-06	189	174	7	2d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D175\|Adult / Lineage, Cell type, age group and donor	COL6A3 CPXM2 SVEP1 KIF7 SCARA5 ADAMTS15 PDZRN3	1.00e-05	190	174	7	7dcca3469f3a3b70db0420cb94f7765f39492f06
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 AQP4 GSTA4 ITPR3 HHIP ST3GAL5 SLC22A31	1.04e-05	191	174	7	6cb2c107bc674aa173b4009f320a1687a76f3979
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 CPXM2 LIN7A SHISA9 HHIP SCARA5 PDZRN3	1.04e-05	191	174	7	24dc77ee8de01b42559f92721655f4281b114e17
ToppCell	facs-Aorta-Heart-18m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 GAS7 SVEP1 TGFBI CLEC11A SCARA5	1.07e-05	192	174	7	6d4fe7ea278efa4b9d43f8a3c282bc0e0e9abaea
ToppCell	facs-Aorta-Heart-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 GAS7 SVEP1 TGFBI CLEC11A SCARA5	1.07e-05	192	174	7	2c6406bc97c3224099b94a43f2890f057b528fa6
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	COL6A3 GAS7 EMILIN1 SVEP1 CLEC11A ANGPTL4 ADAMTS15	1.07e-05	192	174	7	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 EMILIN1 SVEP1 SAMD11 SCARA5 ASTN1 PDZRN3	1.07e-05	192	174	7	e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81
ToppCell	facs-Aorta-Heart-18m-Mesenchymal-nan\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CPXM2 GAS7 SVEP1 TGFBI CLEC11A SCARA5	1.07e-05	192	174	7	47aed7c8e6f5ce1084821212a04f568319e65fd6
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell\|Adult / Lineage, Cell type, age group and donor	COL6A3 CPXM2 SVEP1 KIF7 SAMD11 SCARA5 PDZRN3	1.07e-05	192	174	7	d21f0f577156f17c899b08871046a26b88aea011
ToppCell	5'-GW_trimst-2-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	APC2 GAS7 VWDE SHISA9 KIDINS220 KLHDC8A PDZRN3	1.07e-05	192	174	7	56f2388c9c4e19883ae5cff332c77f596ff744a8
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 GAS7 COL6A5 EMILIN1 SVEP1 ADAMTS15 PDZRN3	1.07e-05	192	174	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A3 SYNE1 CRH SLC2A4 TGFBI HHIP SCARA5	1.11e-05	193	174	7	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	COL6A3 SYNE1 CRH SLC2A4 TGFBI HHIP SCARA5	1.11e-05	193	174	7	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL6A3 SVEP1 SAMD11 SCARA5 ADAMTS15 ASTN1 PDZRN3	1.11e-05	193	174	7	9ab47b360bee1d4f1092c2269e58acebe9584021
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL4A3 ABCC3 ARHGEF28 SYNE1 MAP3K1 ITPR3 MAML2	1.15e-05	194	174	7	e577d9e88390b36b5a09b97fe1026089892275a3
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 GAS7 COL6A5 EMILIN1 SVEP1 ADAMTS15 PDZRN3	1.15e-05	194	174	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RASGRF1 AQP4 GSTA4 ITPR3 HHIP ST3GAL5 SLC22A31	1.19e-05	195	174	7	6867f9c56ea27a17c8c4099aae0d79903c3748a5
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 AQP4 ITPR3 HHIP ST3GAL5 LRP2 SLC22A31	1.19e-05	195	174	7	fc0ae145a2118df7cbbc9ac4ca9dc12d26c087c4
ToppCell	343B\|World / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	1.19e-05	195	174	7	2290911fde6efacfa38b985a2541322968bee42d
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A3 NDST1 KLK7 AQP4 LIN7A IL17RE NBEAL2	1.19e-05	195	174	7	68f4cc84b5ae7f4159b780c78e4b66c94211779a
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CPXM2 PRXL2B SPTBN2 MFSD6 GAS7 ERMP1 ALOX12	1.19e-05	195	174	7	c54b19e31efe2c9ae690062569da7c0f1120a1d8
ToppCell	cellseq-Epithelial-Epithelial_Alveolar-AT2\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RASGRF1 AQP4 GSTA4 ITPR3 HHIP ST3GAL5 SLC22A31	1.19e-05	195	174	7	955a0a7244cd7eaf006a39e1bd03333baf6f30a4
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 GAS7 EMILIN1 SVEP1 SCARA5 ANGPTL4 GALNT5	1.19e-05	195	174	7	47762d9e442fb1f6f0033e3e10f4c6e498d2c081
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL4A3 NDST1 KLK7 AQP4 LIN7A IL17RE NBEAL2	1.19e-05	195	174	7	2a1863f4b9fe73c30b0b1acf9b12fc98ef65040f
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 SYNE1 AQP4 ITPR3 HHIP ST3GAL5 SLC22A31	1.19e-05	195	174	7	37aa6e4123d37de4de42ca68d3020f2a7686ce02
ToppCell	3'-Parenchyma_lung-Epithelial\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 SYNE1 AQP4 ITPR3 HHIP ST3GAL5 SLC22A31	1.19e-05	195	174	7	eec187c087e432417bc346c5d3ead72f58bf3215
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 COL6A5 EMILIN1 SVEP1 SAMD11 CLEC11A SCARA5	1.23e-05	196	174	7	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RASGRF1 AQP4 GSTA4 HHIP ST3GAL5 LRP2 SLC22A31	1.23e-05	196	174	7	82b117be41f2e7d677a42d2a5198726eeccb16d0
ToppCell	Tracheal-10x5prime-Stromal-Schwann\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KLK7 APC2 SHC4 GAS7 CHADL SHISA9 SLITRK2	1.23e-05	196	174	7	b6226163d9fc93ecfff2115bb74408303a000490
ToppCell	(7)_Epithelial-B_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	1.23e-05	196	174	7	345d4cc062b43bca9d506fbf23363469a9ba496f
ToppCell	cellseq-Epithelial-Epithelial_Alveolar\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RASGRF1 AQP4 GSTA4 ITPR3 HHIP ST3GAL5 SLC22A31	1.23e-05	196	174	7	a7cbe66ebd8931ef2b8ff26a42afce0ad1c48f17
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 COL6A5 EMILIN1 SVEP1 SAMD11 CLEC11A SCARA5	1.23e-05	196	174	7	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	COL6A3 EMILIN1 SVEP1 GSTA4 HHIP SCARA5 SLC22A31	1.23e-05	196	174	7	988a3e0688e0a7ba69774497d3b130631bb26c50
ToppCell	Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SHC4 SRCIN1 CHADL LIN7A GALNT8 ADAMTS15 KIF25	1.27e-05	197	174	7	06e17c9ad53463eee1007280b3f3e8b0cf446cdc
ToppCell	343B-Epithelial_cells-Epithelial-B_(AT2)\|343B / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP SARS2 LRP2	1.27e-05	197	174	7	f3ca63c7902d7530a29a85eb54f69b303031d150
ToppCell	droplet-Trachea-nan-3m-Mesenchymal-chondrocyte\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL6A3 CHADL PAPSS2 EMILIN1 SLC2A1 ITPR3 CSPG4	1.27e-05	197	174	7	8786125b669d5d0b15e12df0ade6b319f09f7333
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL6A3 GAS7 EMILIN1 SVEP1 CLEC11A MAML2 PDZRN3	1.27e-05	197	174	7	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 NDST4 GAS7 COL6A5 SVEP1 SCARA5 PDZRN3	1.27e-05	197	174	7	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	343B-Epithelial_cells-Epithelial-B_(AT2)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP SARS2 LRP2	1.27e-05	197	174	7	f98720cab066579fdac3ba24fb6fe4c5759dae4e
ToppCell	distal-Epithelial-Alveolar_Epithelial_Type_2-1\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	1.31e-05	198	174	7	19eefd05573fbaed654af52bf0f8a26092b8b229
ToppCell	medial-2-Epithelial-Alveolar_Epithelial_Type_2\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	RASGRF1 AQP4 GSTA4 ITPR3 HHIP LRP2 SLC22A31	1.31e-05	198	174	7	102a4cbb138adbfba11ed955420095daa098532f
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-AT1\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	COL4A3 SH2D3A PAPSS2 AQP4 CRH IL17RE GALNT5	1.31e-05	198	174	7	1282db321e27499d310339d6383974614e295a20
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	NDST4 COL6A5 EMILIN1 SVEP1 SAMD11 ASTN1 PDZRN3	1.31e-05	198	174	7	300d7cc56207d77168390fa1ffcbcf76767b1b80
Drug	AG-013608 [351320-38-2]; Up 200; 10uM; PC3; HT_HG-U133A	ZBTB33 GAS7 IGFLR1 SLC2A1 SVEP1 TGFBI CLEC11A SLITRK5 PPP1R37 GP5	2.66e-06	197	172	10	6400_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Down 200; 6.4uM; PC3; HT_HG-U133A	COL4A3 SETD1A AQP4 SVEP1 ZIC3 KANSL3 KIDINS220 CLEC11A ASTN1 OSBP2	2.91e-06	199	172	10	4071_DN
Drug	2gst	COL4A3 GTPBP1 ITPR3 LRIG1 PKD1 SDHA GP5	4.04e-06	86	172	7	CID000444461
Disease	Intellectual Disability	SETD1A NDST1 SYNE1 APC2 SLC2A1 GTF3C3 KIF7 PNPT1 ST3GAL5 LRP2 ASTN1 NKAP EIF2A	1.76e-06	447	167	13	C3714756
Disease	Global developmental delay	SPTBN2 APC2 SLC2A1 GTF3C3 PNPT1 SLC25A12 NKAP	1.12e-05	133	167	7	C0557874
Disease	response to cisplatin, response to antineoplastic agent	HAO1 SCARA5 VAV3	2.84e-05	11	167	3	GO_0072718, GO_0097327
Disease	Glucocorticoid-remediable aldosteronism	CYP11B1 CYP11B2	3.18e-05	2	167	2	C1260386
Disease	adrenal cortical adenoma (is_marker_for)	CYP11B1 CYP11B2	3.18e-05	2	167	2	DOID:0050891 (is_marker_for)
Disease	cholesteryl esters to total lipids in small LDL percentage	MOGAT2 SIK3 NCAN ANGPTL4	9.37e-05	42	167	4	EFO_0022255
Disease	stomatocytic anemia	PIEZO1 SLC2A1	9.52e-05	3	167	2	C0272048
Disease	Stomatocytosis Result	PIEZO1 SLC2A1	9.52e-05	3	167	2	C0677598
Disease	congenital adrenal hyperplasia (implicated_via_orthology)	CYP11B1 CYP11B2	9.52e-05	3	167	2	DOID:0050811 (implicated_via_orthology)
Disease	forced expiratory volume	SETD1A SLC25A21 SYNE1 PIEZO1 SPTBN2 WHAMM ONECUT1 SVEP1 MAP3K1 PNPT1 HHIP RMC1 FBXL20 NNT	1.69e-04	789	167	14	EFO_0004314
Disease	X-24020 measurement	TUBGCP2 TUBGCP6	3.15e-04	5	167	2	EFO_0022128
Disease	primary hyperaldosteronism (is_implicated_in)	CYP11B1 CYP11B2	3.15e-04	5	167	2	DOID:446 (is_implicated_in)
Disease	apolipoprotein L1 measurement	CYP11B1 CYP11B2 TLE7	3.74e-04	25	167	3	EFO_0021854
Disease	Conn Syndrome	CYP11B1 CYP11B2	4.71e-04	6	167	2	C1384514
Disease	Hyperaldosteronism	CYP11B1 CYP11B2	4.71e-04	6	167	2	C0020428
Disease	azoospermia (implicated_via_orthology)	NDST1 NDST4 NDST3	4.71e-04	27	167	3	DOID:14227 (implicated_via_orthology)
Disease	phospholipids:total lipids ratio, intermediate density lipoprotein measurement	MOGAT2 SIK3 ANGPTL4 PCCB	5.75e-04	67	167	4	EFO_0008595, EFO_0020946
Disease	Developmental Disabilities	SETD1A SLC2A1 LRP2	6.46e-04	30	167	3	C0008073
Disease	NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE	COL4A3 NUP205 CRB2	6.46e-04	30	167	3	C1868672
Disease	protocadherin alpha-7 measurement	CYP11B1 CYP11B2	6.56e-04	7	167	2	EFO_0801973
Disease	vital capacity	NDST1 COL6A3 SLC25A21 SYNE1 PIEZO1 SPTBN2 MFSD6 SVEP1 MAP3K1 PNPT1 HHIP ADAMTS15 LRP2 RMC1 FBXL20 NNT DAGLA	6.75e-04	1236	167	17	EFO_0004312
Disease	Colorectal Carcinoma	ABCC3 SYNE1 SPTBN2 APC2 PREX2 NDST3 FANCG HHIP MCM3AP ADAMTS15 LRP2 HR	6.88e-04	702	167	12	C0009402
Disease	Leigh disease (is_implicated_in)	COX15 SDHA	1.12e-03	9	167	2	DOID:3652 (is_implicated_in)
Disease	Encephalopathy, Subacute Necrotizing, Infantile	COX15 SDHA	1.12e-03	9	167	2	C0751267
Disease	Encephalopathy, Subacute Necrotizing, Juvenile	COX15 SDHA	1.12e-03	9	167	2	C0751268
Disease	protein FAM163B measurement	CYP11B1 CYP11B2	1.12e-03	9	167	2	EFO_0802936
Disease	Developmental delay (disorder)	SPTBN2 SLC2A1 PNPT1	1.20e-03	37	167	3	C0424605
Disease	fish oil supplement exposure measurement, triglyceride measurement	SIK3 NCAN	1.39e-03	10	167	2	EFO_0004530, EFO_0600007
Disease	androstenedione measurement	CYP11B1 CYP11B2	1.39e-03	10	167	2	EFO_0007972
Disease	cell growth regulator with EF hand domain protein 1 measurement	CYP11B1 CYP11B2	1.69e-03	11	167	2	EFO_0801461
Disease	3-hydroxyanthranilate 3,4-dioxygenase measurement	CYP11B1 CYP11B2	1.69e-03	11	167	2	EFO_0021862
Disease	cholesteryl esters to total lipids in small HDL percentage	SIK3 ANGPTL4 PCCB	1.86e-03	43	167	3	EFO_0022254
Disease	congenital diaphragmatic hernia (implicated_via_orthology)	NDST1 KIF7	2.02e-03	12	167	2	DOID:3827 (implicated_via_orthology)
Disease	Drug-induced depressive state	AQP4 HCRT	2.02e-03	12	167	2	C0338715
Disease	chronic kidney disease	COL6A3 COL6A5 NDST3 LRIG1 LRP2 PDZRN3	2.27e-03	235	167	6	EFO_0003884
Disease	Gastrointestinal Stromal Sarcoma	NDST1 HHIP SDHA	2.40e-03	47	167	3	C3179349
Disease	overall survival, pancreatic carcinoma	WHRN LIN7C PREX2	2.71e-03	49	167	3	EFO_0000638, EFO_0002618
Disease	brain ischemia (biomarker_via_orthology)	AQP8 AQP4 CRH CSPG4	2.73e-03	102	167	4	DOID:2316 (biomarker_via_orthology)
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	MOGAT2 SIK3 ANGPTL4 PCCB	2.83e-03	103	167	4	EFO_0008595, EFO_0020944
Disease	Gastrointestinal Stromal Tumors	NDST1 HHIP SDHA	2.87e-03	50	167	3	C0238198
Disease	cholesteryl esters to total lipids in IDL percentage	SIK3 ANGPTL4 PCCB	2.87e-03	50	167	3	EFO_0022247
Disease	epithelial cell adhesion molecule measurement	PRORSD1P PNPT1 ASB3	3.04e-03	51	167	3	EFO_0010574
Disease	cholesterol to total lipids in small HDL percentage	SIK3 ANGPTL4 PCCB	3.04e-03	51	167	3	EFO_0022240
Disease	Alopecia, Male Pattern	CRH HR	3.19e-03	15	167	2	C4083212
Disease	Androgenetic Alopecia	CRH HR	3.19e-03	15	167	2	C0162311
Disease	Female pattern alopecia (disorder)	CRH HR	3.19e-03	15	167	2	C0263477
Disease	triglycerides in HDL measurement	SIK3 ANGPTL4 PCCB	3.39e-03	53	167	3	EFO_0022317
Disease	free cholesterol to total lipids in small LDL percentage	SIK3 ANGPTL4 PCCB	3.39e-03	53	167	3	EFO_0022286
Disease	fatty acid measurement	MOGAT2 GAS7 SIK3 SHISA9 NCAN ANGPTL4 PCCB DAGLA	3.51e-03	436	167	8	EFO_0005110
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	SIK3 NCAN ANGPTL4 PCCB	3.59e-03	110	167	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	SIK3 NCAN ANGPTL4 PCCB	3.59e-03	110	167	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	level of triacylglycerol (56:6) in blood serum	SIK3 NCAN	3.63e-03	16	167	2	OBA_2020007
Disease	phosphatidylcholine 38:6 measurement	ABCC3 SLC25A21	3.63e-03	16	167	2	EFO_0010388
Disease	triglycerides in very large HDL measurement	SIK3 ANGPTL4 PCCB	3.76e-03	55	167	3	EFO_0022324
Disease	triglycerides in LDL measurement	SIK3 ANGPTL4 PCCB	3.96e-03	56	167	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	SIK3 ANGPTL4 PCCB	3.96e-03	56	167	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	SIK3 ANGPTL4 PCCB	3.96e-03	56	167	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	SIK3 ANGPTL4 PCCB	3.96e-03	56	167	3	EFO_0022316
Disease	cholesteryl esters to total lipids in medium HDL percentage	SIK3 ANGPTL4 PCCB	3.96e-03	56	167	3	EFO_0022251
Disease	muscular dystrophy (is_implicated_in)	COL6A3 SYNE1	4.10e-03	17	167	2	DOID:9884 (is_implicated_in)
Disease	triglycerides in IDL measurement	SIK3 ANGPTL4 PCCB	4.37e-03	58	167	3	EFO_0022149
Disease	free cholesterol in medium HDL measurement	MOGAT2 SIK3 ANGPTL4	4.37e-03	58	167	3	EFO_0022267
Disease	triglycerides in VLDL measurement	SIK3 ANGPTL4 PCCB	4.59e-03	59	167	3	EFO_0022326
Disease	triglycerides to total lipids in small LDL percentage	SIK3 ANGPTL4 PCCB	4.59e-03	59	167	3	EFO_0022337
Disease	cholesterol in medium HDL measurement	MOGAT2 SIK3 ANGPTL4	4.59e-03	59	167	3	EFO_0021903
Disease	concentration of chylomicrons and extremely large VLDL particles measurement	SIK3 ANGPTL4 PCCB	4.59e-03	59	167	3	EFO_0022260
Disease	omega-3 polyunsaturated fatty acid measurement	MOGAT2 NCAN ANGPTL4 DAGLA	4.61e-03	118	167	4	EFO_0010119
Disease	triglycerides to total lipids in large HDL percentage	SIK3 ANGPTL4 PCCB	4.81e-03	60	167	3	EFO_0022330
Disease	total lipids in VLDL measurement	SIK3 ANGPTL4 PCCB	4.81e-03	60	167	3	EFO_0022314
Disease	cholesterol to total lipids in IDL percentage	SIK3 ANGPTL4 PCCB	4.81e-03	60	167	3	EFO_0022233
Disease	triglycerides in small VLDL measurement	SIK3 ANGPTL4 PCCB	5.04e-03	61	167	3	EFO_0022145
Disease	free cholesterol in very large VLDL measurement	SIK3 ANGPTL4 PCCB	5.04e-03	61	167	3	EFO_0022274
Disease	free cholesterol in HDL measurement	MOGAT2 SIK3 ANGPTL4	5.04e-03	61	167	3	EFO_0022264
Disease	phospholipids in HDL measurement	MOGAT2 SIK3 ANGPTL4	5.04e-03	61	167	3	EFO_0022293
Disease	acetone measurement	VWA8 SLC2A4	5.11e-03	19	167	2	EFO_0010989
Disease	Pseudopelade	CRH HR	5.11e-03	19	167	2	C0086873
Disease	Alopecia	CRH HR	5.11e-03	19	167	2	C0002170
Disease	sphingomyelin measurement	MOGAT2 CYP27B1 SIK3 PELP1 NCAN ANGPTL4	5.16e-03	278	167	6	EFO_0010118
Disease	triglycerides in small HDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022158
Disease	phospholipids in large VLDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022169
Disease	hypertension, white matter hyperintensity measurement	NBEAL1 MAP3K1 PNPT1	5.27e-03	62	167	3	EFO_0000537, EFO_0005665
Disease	triglycerides in medium LDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022322
Disease	total lipids in chylomicrons and extremely large VLDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022306
Disease	total lipids in very large VLDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022313
Disease	phospholipids in very large VLDL measurement	SIK3 ANGPTL4 PCCB	5.27e-03	62	167	3	EFO_0022299
Disease	triglycerides to total lipids in IDL percentage	SIK3 ANGPTL4 PCCB	5.51e-03	63	167	3	EFO_0022329
Disease	total lipids in HDL measurement	MOGAT2 SIK3 ANGPTL4	5.51e-03	63	167	3	EFO_0022307
Disease	free cholesterol to total lipids in medium LDL percentage	SIK3 ANGPTL4 PCCB	5.51e-03	63	167	3	EFO_0022283
Disease	phospholipids in chylomicrons and extremely large VLDL measurement	SIK3 ANGPTL4 PCCB	5.51e-03	63	167	3	EFO_0022292

Protein segments in the cluster

Peptide	Gene	Start	Entry
RQAGLGNHLSGSERL	TGFBI	396	Q15582
HGNLTAGHGLLVELI	AQP4	151	P55087
LAGNGLVLATHLAAR	CCR10	56	P46092
HGLLQLGQGLREHAE	ANGPTL4	46	Q9BY76
LQHLEGQLGSLQGRA	CCDC88B	1001	A6NC98
QAQLDGGLVLFSHRG	CSPG4	1536	Q6UVK1
RAHGQDLGTLGSCLQ	COL4A3	1481	Q01955
LGRLQAHEGSEGIFL	ADAM18	11	Q9Y3Q7
LLGVLTHGELDNGRG	GTPBP1	176	O00178
AEHLAGHEGVQLLGL	CCNG2	6	Q16589
LLAGTLGVAQHREAL	DPH2	286	Q9BQC3
AHGLALGLVIATLGN	AQP8	71	O94778
SLQQLVLRGAAGHRG	ERMP1	91	Q7Z2K6
SVLIGGHGRESLRNA	ASTN1	206	O14525
HLLGATGIEDRLQDG	ATP10A	856	O60312
VGHGGRLLARDQCNL	ADAMTS15	921	Q8TE58
LAEHDAVRNALAGGL	ASCL2	106	Q99929
LGAHRGRLNIQAGIN	CPXM2	161	Q8N436
AGAHGNEVLGRELLL	CPXM2	376	Q8N436
LGLHDGIQRVLFGNN	NDST3	261	O95803
LLHLFGAIVAGGQRN	NBEAL1	216	Q6ZS30
LRAHNGALQARLGAL	PDZRN3	166	Q9UPQ7
HKSRLLQASEGGLAG	PCDHGA11	721	Q9Y5H2
QESIGLAIHLLDGGN	ITPR3	1751	Q14573
RNGENGIHFLLNRDG	GRSF1	176	Q12849
GLNVADIGLHDLRSQ	ABCC3	1351	O15438
GHIGRFQRQCLGLLS	NUP205	1706	Q92621
QQEGLSLGHSILRGG	ARHGEF28	1406	Q8N1W1
GGLSRLHELQVQGAA	CYP27B1	56	O15528
GELVGARLIAHAGSL	NOP58	291	Q9Y2X3
QGLNKGLTATLGRHG	SLC25A21	166	Q9BQT8
LDGDNVRHGLNRNLG	PAPSS2	76	O95340
GRGHADIVHLLLQNG	KIDINS220	146	Q9ULH0
HGGLKRGDQLLSVNG	LIN7A	146	O14910
HGGLKRGDQLLSVNG	LIN7B	131	Q9HAP6
HGGLKRGDQLLSVNG	LIN7C	131	Q9NUP9
ALVLGHILLNGNRAR	MAGEE2	181	Q8TD90
EGLEHLNLGGNAIRS	LRIG1	406	Q96JA1
GSLLNSLNEQRGHGL	ZBTB33	16	Q86T24
ALRGALGTLHQLGIV	SLC2A1	151	P11166
LGQHVHVGGRLLAAD	CRB2	741	Q5IJ48
THLRGALGTLNQLAI	SLC2A4	166	P14672
NLARGLLDLGHAGRL	MCM3AP	1291	O60318
CQHLLSGGSGLQRGL	IL17RE	81	Q8NFR9
SGGSGLQRGLFHLLV	IL17RE	86	Q8NFR9
GERSGHKNLALEGLR	CCDC120	546	Q96HB5
LNSGGHLQRAGEAER	HR	231	O43593
AQGLQQELGGLHSAL	INTS2	696	Q9H0H0
GLNGILVSNHGARQL	HAO1	251	Q9UJM8
LNAQGHGQLLGTARE	ONECUT1	256	Q9UBC0
LLLQQSRDHLGEGLA	KIF7	1166	Q2M1P5
GLHDGIQRVLFGNNL	NDST1	271	P52848
ALLSGNQLHCGGVLV	KLK7	46	P49862
ENNLRTLSSQHGLGG	LCN6	66	P62502
NELLSLLRVHGGDGA	TUBGCP2	11	Q9BSJ2
LHQGELQLLAGGVLQ	TUBGCP6	326	Q96RT7
HLNNVSTGCILLGGL	HM13	201	Q8TCT9
LDGLFVSDLNGGHRR	LRP2	3291	P98164
ALHLDGNRLTSLGEG	LRFN3	111	Q9BTN0
SLGEGQLRGLVNLRH	LRFN3	121	Q9BTN0
LGRLGNVNTLGLDHN	LRFN3	176	Q9BTN0
QLAQDALEGLRGLLH	FANCG	41	O15287
ALEGLRGLLHSLQGL	FANCG	46	O15287
GGGGHVQLLRRAAAQ	ALOX12	421	P18054
GLHDGIQRVLFGNNL	NDST4	261	Q9H3R1
ALAERGARNALGGHQ	CRH	131	P06850
TARGLNGRGHALLIL	DDX18	516	Q9NVP1
LRTSAQGILQGLHLG	MFSD6	566	Q6ZSS7
CLLRLHGSVGGAQNL	PELP1	71	Q8IZL8
HGAALQRSLTELDGL	OSBP2	326	Q969R2
GTGGLVKNSFHLLRQ	RICTOR	1471	Q6R327
GNEGVRHLKNGLISN	PPP1R37	346	O75864
ALLGGGQRRIDAQHK	PCCB	46	P05166
LLSLVQHGQGARKAG	MAML2	76	Q8IZL2
ESAAHILNRKGGGNL	MOGAT2	166	Q3SYC2
RAGLADVAHILNGLA	CPLANE2	221	Q9BU20
RGHGQSFLVGNQLSL	GSTA4	141	O15217
LLLQILHGTEAAAGG	APC2	316	O95996
DVLRLLLQHGANVNG	ASB3	126	Q9Y575
RHGLGNLLLSELAQN	C4orf50	101	Q6ZRC1
LRGELQQLSGSQLHG	CCPG1	396	Q9ULG6
HGLIRARLAGAQNAT	GALNT5	566	Q7Z7M9
GTLQNLFTGGLHREL	GALNT8	31	Q9NY28
VDESLGTGGNLRHLQ	COL6A5	241	A8TX70
GTGGNLRHLQTFLEN	COL6A5	246	A8TX70
DILGHLRQLQLQGGS	COL6A3	701	P12111
GQLGTHLAQLGRADA	IGFLR1	326	Q9H665
GQGGLHLALLVQRAD	GIMD1	101	P0DJR0
NVGALHFRLGNLGEA	CTR9	456	Q6PD62
NLALFGERLGLVGHS	CYP11B1	201	P15538
GVLQLQLGLDGHRTL	MAN2A2	716	P49641
SRGELALHNGRLGDS	DAGLA	891	Q9Y4D2
ANLGLELGTNLHLAI	ENO4	381	A6NNW6
LRKGHGTLGQGLSAL	FIBCD1	161	Q8N539
QGLGELQVLALHSNG	GP5	336	P40197
HLLNNGSGVGVLQCL	KANSL3	311	Q9P2N6
DNHLYSLGGLRQGRL	KLHDC8A	221	Q8IYD2
AQSRGASLLQRLHNG	KHNYN	336	O15037
GHGARSLLQFLRLVG	HDDC2	11	Q7Z4H3
NLALFGERLGLVGHS	CYP11B2	201	P19099
RLGQLEGLLQAHGDE	EMILIN1	566	Q9Y6C2
AGGLQGLREGLSRHV	EMILIN1	741	Q9Y6C2
GHILVLAGFGNLRGQ	EIF2A	326	Q9BY44
QLLQLRRFAHGTAGL	COX15	256	Q7KZN9
LSQARGLARLELGHN	CHADL	226	Q6NUI6
HAGLCGLQGLAVLLL	CELSR3	2756	Q9NYQ7
TLQEALGALHRVGGN	RSC1A1	586	Q92681
LGALHRVGGNADLAL	RSC1A1	591	Q92681
GRHTTQAAALLLAGG	SLC22A8	381	Q8TCC7
LRLLHGGTLAGALLA	SLC22A31	186	A6NKX4
ADVGGVLRGLNHSLS	SCARA5	221	Q6ZMJ2
QDRGLNIHALLAGLG	SLC45A1	261	Q9Y2W3
LHGLSGRLRVGALSQ	MENT	226	Q9BUN1
GDRNGLTHQLGGLSQ	NKAP	51	Q8N5F7
GSNLRQLARGQAGHG	PKD1	3431	P98161
GNLGLITLFGLNSHL	OR8B2	41	Q96RD0
ALLTGGGSENRNHRL	RNF180	151	Q86T96
AGNHAAGILTLGKRR	HCRT	56	O43612
LSGLLALHLNGNRLT	NYX	301	Q9GZU5
RLSHDVSGALLLANG	MAP3K1	586	Q13233
GRHLLNAGLLAASVG	NNT	776	Q13423
SLAGLLDQHGVRLVG	PRXL2B	56	Q8TBF2
QLGGTRTNKGLQLRH	RTF1	416	Q92541
LRGAGALLQHGLVNF	SARS2	231	Q9NP81
GNELRSLHGLEQLRN	STK11IP	241	Q8N1F8
DAILGLAHHGNGQLR	CARS2	421	Q9HA77
QSLQGHLAKLGSLGR	SYNE1	1821	Q8NF91
GSLGRAEDLHLLQGK	SYNE1	1831	Q8NF91
KLSQRGQLLSEEGHG	SYNE1	2576	Q8NF91
VHGANRLGANSLLDL	SDHA	446	P31040
LGLRKAHSGAQGLLA	YARS2	26	Q9Y2Z4
LLGGQGGQLQLLHLA	TAF1C	506	Q15572
GGQLQLLHLAGEGAS	TAF1C	511	Q15572
ELITDDGIRHLGNGA	FBXL20	336	Q96IG2
RHGQGLRFAAGELIT	GAS7	16	O60861
GRGTQLENVALHALL	NBEAL2	126	Q6ZNJ1
LGAALEQRLGALAIH	PRORSD1P	6	A6NEY8
LLGGCSGRIHQLALT	GPR108	26	Q9NPR9
RRQGAALASVGQLHL	NCAN	281	O14594
LHLGNNGLQEIRTGA	SLITRK2	91	Q9H156
LGRRASDGGANIQLH	SIK3	546	Q9Y2K2
RAGHGQLAQLGGVLL	SHISA9	26	B4DS77
GGILHGLELGHTLNQ	ST3GAL5	201	Q9UNP4
LQRRGALLVLNHGAA	SAMD11	391	Q96NU1
GIIRGAHQNRGLGSA	MTG2	281	Q9H4K7
EAGSGDVLHLALLQR	SWSAP1	146	Q6NVH7
QEGDRRSTLHLLQGG	WHRN	261	Q9P202
LLSAAGLRGAHRQLA	WHAMM	81	Q8TF30
ELLNRGLGVHHSGIL	SKIV2L	626	Q15477
DTERNLGLLLGLHAS	HERC2P3	31	Q9BVR0
HLAQTLQGLGFGIRA	KIF25	346	Q9UIL4
AVNDLGHLLGRAGFN	NDUFAF5	221	Q5TEU4
TGLNRRELGHGALAE	PNPT1	441	Q8TCS8
GHILAGSDLRLCLEN	SVEP1	2746	Q4LDE5
RLNDGHVASLGLLAR	RASGRF1	6	Q13972
HQLRQGKGLIAASAG	SETD1A	691	O15047
GALHSGDGSQRLFIL	HHIP	231	Q96QV1
NLGRGLHQLGLIHLA	GTF3C3	816	Q9Y5Q9
KLLLADENGHVGGLN	SLC25A12	506	O75746
ILGRLAGLDAGLHQL	CLEC11A	111	Q9Y240
SGLQGGQAKHLLLVD	SHC4	561	Q6S5L8
LKTIGQGREHLGLNL	VWDE	336	Q8N2E2
NNQVHLGLRGELFGR	ZIC3	181	O60481
LLGSGHVGLRNLGNT	USP21	206	Q9UK80
IQALTRAGHGALQAG	TTC24	36	A2A3L6
SGGSLQGHDAVLRLV	NGDN	76	Q8NEJ9
LNGGRHVQGILRGFD	SNRPG	21	P62308
KGRLQSQDLGRHLAG	SPTBN2	551	O15020
GLLHEGRLSLAAAAG	SRCIN1	401	Q9C0H9
EATGLDLLHLGNNRI	SLITRK5	431	O94991
LAALRFIRGIGGHDN	RMC1	576	Q96DM3
RHQTLALAGALAVLG	SH2D3A	366	Q9BRG2
GTLAVSRGLGDHQLR	PPM1M	331	Q96MI6
GDGLHLRLQTQAKLG	UBE3D	76	Q7Z6J8
LNGGRHVQGILRGFD	SNRPGP15	21	A8MWD9
LAGLQQANRHHGLLG	UBE2J2	216	Q8N2K1
HGLLGGALANLFVIV	UBE2J2	226	Q8N2K1
HLQGLGRSELQAAGL	TLE7	76	A0A1W2PR48
LSLGQQDGHGLRYLL	PREX2	1001	Q70Z35
GGHLLQFLSCLENGL	SGSM1	356	Q2NKQ1
GAALAGHQLIRGLGQ	PRKDC	26	P78527
GRSHLQGSLAALGEA	nan	166	Q6ZR54
VHELRQGLARLGGGN	SLC25A23	31	Q9BV35
GLQGHTGRLLRALLG	PIEZO1	51	Q92508
FLLGEHLLLVGNQGV	VWA8	771	A3KMH1
ARTQHGLALARLQGQ	PSPN	101	O60542
GLALARLQGQGRAHG	PSPN	106	O60542
LADALSRGHVLGGSQ	USP32	1441	Q8NFA0
LLHLTLQGQRGGICA	TTC31	416	Q49AM3
RFGLARLLGSQDHGD	nan	26	Q8N3U1
HSAGQRGNRAGNSLL	VAV3	771	Q9UKW4
LHLDGNRLVELGTGS	LRFN4	101	Q6PJG9